220 results
Page 8 of 11
424B5
9wbmjomyp3pol4uz9
13 May 19
Prospectus supplement for primary offering
8:04am
8-K
EX-10.2
zex1emu0m
13 May 19
Arch Therapeutics, Inc. $2.8 Million Registered Direct Offering
7:59am
8-K
EX-10.1
qrl2bnk7zqwd
13 May 19
Arch Therapeutics, Inc. $2.8 Million Registered Direct Offering
7:59am
8-K
EX-99.1
k5wvjbm
24 Apr 19
Arch Therapeutics Announces Attendance at 2019 Symposium on Advanced Wound Care Conference (SAWC) and Release of a New AC5TM Topical Gel Video
7:59am
S-8
EX-23.2
7ntu5xu zeemgvc
19 Dec 18
Registration of securities for employees
7:33am
8-K
EX-99.1
qllu 82vezqg
6 Dec 18
Arch Therapeutics Provided Corporate Update at the 11th Annual LD Micro Main Event
7:57am
8-K
EX-99.1
x6db5nhwl
28 Nov 18
Arch Therapeutics Announces Submission of CE Mark File for AC5™ Topical Hemostat in Europe
8:00am
8-K
EX-99.1
jpeg3o95nc7qesx
26 Nov 18
Company to provide regulatory filing status update
9:05am
8-K
EX-10.4
hjf4x71l4wb3jsu30
20 Jul 18
Arch Therapeutics Appoints Healthcare Industry Executive Punit Dhillon to Board of Directors
7:38am
8-K
EX-99.1
o1kk86o0d96h1u
20 Jul 18
Arch Therapeutics Appoints Healthcare Industry Executive Punit Dhillon to Board of Directors
7:38am
424B5
d0lh46a6 mvx4i4wx
29 Jun 18
Prospectus supplement for primary offering
8:22am
8-K
EX-10.1
cx473uv
29 Jun 18
Arch Therapeutics, Inc. $4.5 Million Registered Direct Offering
8:16am
8-K
EX-10.2
8es5doja
29 Jun 18
Arch Therapeutics, Inc. $4.5 Million Registered Direct Offering
8:16am